Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
FalconPoint Partners’ Investment in JENNMAR
Lowenstein Sandler and Paul, Weiss, Rifkind, Wharton & Garrison represented FalconPoint Partners in the transaction, while Jones Day served as legal advisor to JENNMAR. FalconPoint Partners,...
CIVC Partners’ Acquisition of Datavail Corp.
Kirkland & Ellis LLP served as legal counsel to CIVC, while Lowenstein Sandler LLP served as legal counsel to Catalyst Investors and Datavail on the transaction....
Nord Anglia Education’s Acquisition of Avenues New York and Avenues São Paulo Schools
Lowenstein Sandler represented Avenues Global Holdings in the transaction. Avenues Global Holdings, LLC executed the sale of two of the world’s top independent schools, Avenues New...
Williams Industrial Services Group’s Chapter 11 Bankruptcy
Lowenstein Sandler’s Bankruptcy & Restructuring Department has been selected as counsel to the Official Committee of Unsecured Creditors in the Chapter 11 bankruptcy of Williams Industrial...
Coffee Holding Co’s Merger With Delta Corp Holdings Ltd.
Lowenstein represented Coffee Holding Co, Inc. in the transaction. The U.S.-based wholesale coffee roaster and dealer Coffee Holding Co, Inc. announced its definitive merger and share exchange...
WebPT’s Acquisition of Clinicient
Lowenstein represented Clinicient in the transaction, while Willkie Farr & Gallagher advised Clinicient. WebPT announced its acquisition of Clinicient, a portfolio company of Catalyst Investors. The acquisition provides additional...
Progress’ $258 Million Acquisition of Kemp
Wilmer Cutler Pickering Hale and Dorr advised Progress on the deal, while Lowenstein represented Mill Point Capital. Progress, the leading provider of products to develop, deploy...